key: cord-0937959-r9v7r4k3 authors: Coleman, P.; Gajraj, R.; Chandan, J. S.; Roy, A.; Lumby, V.; Taylor, A.; Newton, P.; Swindells, J.; O'Moore, E. title: Implementation of novel and conventional outbreak control measures in managing a COVID-19 outbreak in a large UK prison date: 2020-12-11 journal: nan DOI: 10.1101/2020.12.07.20234641 sha: 8707ab1034290602a2c2851ec66f42a558bacd2f doc_id: 937959 cord_uid: r9v7r4k3 Background: SARS-CoV-2 can spread rapidly within correctional facilities. On 22nd March 2020, following identification of a confirmed COVID-19 case in a prisoner in Prison A (UK), an Outbreak Control Team was convened consisting of prison staff and public health experts from Public Health England and the UK National Health Service. Methods: At the start of the outbreak, four prisoners and 40 staff were isolating with COVID-19 symptoms. An outbreak was declared and full prison lockdown implemented. Prompt implementation of novel outbreak control measures prevented an explosive prison outbreak, specifically establishment of dedicated isolation and cohorting units, including (i) Reverse Cohorting Units (RCUs) for accommodating new detainees; (ii) Protective Isolation Units (PIUs) for isolating symptomatic prisoners (new detainees and existing residents), and (iii) Shielding Units (SUs) to protect medically vulnerable prisoners. Findings: In total, 120 probable and 25 confirmed cases among prisoners and staff were recorded between March and June 2020. Among prisoners, there were six possible, 79 probable, and three confirmed cases. Among staff, there were 83 possible, 79 probable, and 22 confirmed cases. Testing of symptomatic prisoners was limited for most of the outbreak, with only 33% of probable cases tested. This explains the low number of confirmed cases (three) among prisoners despite the large number of probable cases (n=81; 92%). Over 50% of the initial cases among prisoners were on the two wings associated with the index case. Interpretation: Rapid transmission of SARS-COV-2 was prevented through proactive steps in identifying and isolating infected prisoners (and staff), cohorting new admissions and shielding vulnerable individuals. These novel and cost-effective approaches can be implemented in a wide range of correctional facilities globally and proved effective even in the absence of mass testing. both focusing on prisons in the USA. Outbreak guidance identified during the literature review was 23 typically adapted from other institutional settings such as care homes and hospital, with a focus on 24 self-isolation, social distancing, reduced admissions and rapid testing. Many of these features form 25 the basis of CDC, WHO and ECDC prison outbreak guidance. However, these measures have not 26 proven effective in many countries, resulting in major and sustained COVID-19 outbreaks in regions 27 such as the USA and South America. Therefore, alternative and cost-effective approaches need to be 28 considered to reduce the transmission of SARS-COV-2. 29 This study outlines novel outbreak control measures (not reported elsewhere in the literature), that 31 were clearly efficacious in preventing the rapid transmission of SARS-COV-2 in a large UK prison. 32 These include: (1) the timely establishment of "Reverse Cohorting Units" to accommodate new 33 prison admissions, allowing emergent infectious cases to be detected before entering the general 34 population; (2) "Protective Isolation Units" for accommodating confirmed / suspected cases and (3) 35 "Shielding Units" to protect prisoners most at risk from Implications of all the available evidence 37 The innovative and cost-effective interventions presented here proved effective in controlling the is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020 Findings: In total, 120 probable and 25 confirmed cases among prisoners and staff were recorded 55 between redacted. Among prisoners, there were six possible, 79 probable, and three confirmed 56 cases. Among staff, there were 83 possible, 79 probable, and 22 confirmed cases. Testing of 57 symptomatic prisoners was limited for most of the outbreak, with only 33% of probable cases 58 tested. This explains the low number of confirmed cases (three) among prisoners despite the large 59 number of probable cases (n=81; 92%). Over 50% of the initial cases among prisoners were on the 60 two wings associated with the index case. 61 Interpretation: Rapid transmission of SARS-COV-2 was prevented through proactive steps in 62 identifying and isolating infected prisoners (and staff), cohorting new admissions and shielding 63 vulnerable individuals. These novel and cost-effective approaches can be implemented in a wide 64 range of correctional facilities globally and proved effective even in the absence of mass testing. 65 Funding Source: none 66 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 35 million 68 people globally, with over 1 million deaths. 1 The focus of interest has been the impact of COVID-19 69 on healthcare and community settings, 2,3 however, the propensity for explosive COVID-19 outbreaks 70 is of particular concern within prisons and places of detention, 4 particularly as a second wave of 71 COVID-19 affects many countries. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.07.20234641 doi: medRxiv preprint Prison A was notified of a confirmed COVID-19 case in a prisoner (index case) on redacted. The case 92 was tested for SARS-CoV-2 following admission to hospital on redacted. The case did not display 93 COVID-19 symptoms and was discharged on redacted the first Outbreak Control Team meeting was 94 convened (attended by Prison A, PHE public health experts and NHS representatives), four prisoners 95 and 40 staff were isolating with COVID-19 symptoms. An outbreak was declared and prison 96 lockdown implemented (i.e. cessation of all admissions/transfers from courts and other prisons). The 97 outbreak was declared over following on redacted when there had been no confirmed cases among 98 staff or prisoners for over 28 days. 99 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.07.20234641 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.07.20234641 doi: medRxiv preprint and tested using the cobas® SARS-CoV-2 dual target real time PCR assay (Roche Diagnostics, 150 Switzerland). Results were returned electronically to the prison healthcare team. 151 An epidemic curve was constructed for staff and prisoners using date of onset of symptoms 153 The attack rate (AR) was calculated for each prison wing using occupancy data from the start of the 158 outbreak. Prisoner location is defined as the wing the prisoner was located on when symptoms first 159 developed or immediately prior to being tested if asymptomatic. 160 Between redacted, 88 prisoners (n = 950, 35.2%) and 184 staff were identified as possible, probable 163 or confirmed COVID-19 cases (Table 1) . 164 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020 Among prisoners, date of onset of symptoms ranged from redacted (Fig. 2) . All three confirmed 169 cases and 22 (35%) of the probable cases occurred in the 29-day period before the PIU and RCU 170 were established on redacted. Over the remainder of the outbreak there were no further confirmed 171 cases and 23 probable cases among the resident population -and 15 probable cases imported from 172 the courts. Four prisoners required hospitalisation. All positive cases were isolated in the PIU as per 173 national guidance. 15 174 All seven wings reported probable or confirmed cases of COVID-19, with at least one case identified 175 on each wing before the PIU and RCU were established on redacted. The attack rate (AR) among 176 prisoners was greatest on D-wing, at 20.0%, followed P-wing (7.8%) and L-wing (5.7%). The attack 177 rate was lowest on K-wing, at 2.9%. Following the PIU and RCU being implemented on the redacted, is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.07.20234641 doi: medRxiv preprint Among staff, there were 83 possible cases, 79 probable cases, and 22 confirmed cases. Two of the 181 22 confirmed cases had no symptoms and four had atypical symptoms. Only 18 (23%) of the 79 182 probable staff cases were tested for SARS-CoV-2. Onset of symptoms ranged from redacted. One 183 staff member required hospitalisation (Fig. 2) . 184 185 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. This is the first COVID-19 outbreak report in a European prison setting. In the absence of adequate 190 SARS-CoV-2 testing, Prison A was able to control the outbreak through the prompt implementation 191 of novel (RCUs, PIUs and SUs) and standard (social distancing, enhanced cleaning) outbreak control 192 measures. In total, 120 probable and 25 confirmed cases among prisoners and staff were recorded. 193 Here we focus on two main issues that merit further discussion: is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint This investigation has several limitations. Inadequate community and prison testing during the early 231 stages of the outbreak means there is likely an under estimate of confirmed cases among prisoners 232 and staff. As Prison A introduced multiple interventions over a similar timeframe it is difficult to 233 ascertain effectiveness of individual interventions. Due to the nature of the data collected it is not 234 possible to make inferences into behavioural/socio-economic risk factors associated with infection. 235 In conclusion, In the absence of a vaccine or effective treatment, risks of large outbreaks in prison 236 settings will continue for the foreseeable future. These risks may be escalated as wider community 237 restrictions are relaxed, a second wave of COVID-19 affects many countries and new prison 238 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 11, 2020. ; https://doi.org/10.1101/2020.12.07.20234641 doi: medRxiv preprint World Health Organisation. Coronavirus disease (COVID-19) Situation Report-202 Presymptomatic SARS-CoV-2 infections and 247 transmission in a skilled nursing facility Epidemiology of covid-19 in a long-term care facility 249 in King County, Washington Prisons and custodial settings are part of a comprehensive 251 response to COVID-19 COVID-19 Cases and Deaths in Federal and 253 State Prisons HM Prison and Probation Service COVID-19 Official Statistics COVID-19 in Prisons and Jails in the United States Flattening the curve for incarcerated populations -Covid-259 19 in jails and prisons Centers for Disease Cotrol and Prevention. Guidance on Management of Coronavirus Disease 261 2019 (COVID-19) in Correctional and Detention Facilities Preventing major outbreaks of COVID-19 in jails The effectiveness of interventions 267 to reduce COVID-19 transmission in a large urban jail Coronavirus-19: The impact on prisons World Health Organisation. Preparedness, prevention and control of Covid-19 in prisons and 273 other places of detention COVID-19 population management strategy for prisons Multi-agency contingency plan for the management of outbreaks of 280 communicable diseases or other health protection incidents in prisons and other places of 281 detention in England Estimates of the severity of coronavirus disease 2019: a 284 model-based analysis Estimating the asymptomatic proportion of 286 coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship Quantifying SARS-CoV-2 transmission suggests Temporal dynamics in viral shedding and transmissibility of 291 COVID-19 Viral dynamics in mild and severe cases of COVID-19 European Centre for Disease Prevention and Control. Infection prevention and control and 295 surveillance for coronavirus disease (COVID-19) in prisons in EU/EEA countries and the UK Prevention of transmission of HIV, hepatitis B 299 virus, hepatitis C virus, and tuberculosis in prisoners Prisons are "in no way equipped" to deal with COVID-19 Outbreak of COVID-19 and Interventions in One of the 303 the United States: Cook County, IL, 2020. Preprint from medRxiv 2020